Charles Goodwin

Track

Insider profile

Currently holds a position at Apyx Medical Corp

Performance

Overall performance
3.4
Performance over holding periods
3.4
30 days 90 days 120 days
Average return 30% 8.2% 15.1%
Success rate 71% 68% 82%
Transactions
4 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Executive Officer, Director Apyx Medical Corp Dec. 15, 2017 -
Charles Goodwin's trades of Apyx Medical Corp's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
421.21
Quantity 82,726 +25.7%
Value US$4,449,039
Transaction date
Purchase
Price
252.85
Quantity 94,055 -23.0%
Value US$4,752,689
Transaction date
Purchase
Price
343.84
Quantity 76,019 +3.7%
Value US$1,178,559
Transaction date
Purchase
Price
3.30
Quantity 28,250 +inf%
Value US$93,197
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-11-15 2023-11-14
B Purchase
82,726 +25.7%
421.21
US$4,449,039 		82,726 +25.7% 421.21 US$4,449,039
2022-08-31 2022-08-29
B Purchase
94,055 -23.0%
252.85
US$4,752,689 		94,055 -23.0% 252.85 US$4,752,689
2022-08-31 2022-08-29
B Purchase
76,019 +3.7%
343.84
US$1,178,559 		76,019 +3.7% 343.84 US$1,178,559
2020-05-14 2020-05-13
B Purchase
28,250 +inf%
3.30
US$93,197 		28,250 +inf% 3.30 US$93,197